drugset / Trial / NCT07679139

Endoscopic Application of Hemostatic Drug Powder in Lower Gastrointestinal Bleeding: A Pilot Study

NCT07679139

Not yet recruiting 60 enrolled National Cheng-Kung University Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

This clinical trial will enroll patients at National Cheng Kung University Hospital. All patients who are hospitalized for lower gastrointestinal bleeding and undergo colonoscopy will be invited to participate. This study uses random allocation, with one Intervention group and one Standard group. Both groups will receive standard endoscopic hemostasis. Afterward, patients in the Intervention group will receive local administration of 1.5 g of tranexamic acid and 3 g of sucralfate. Following the endoscopic procedure, patients will be directly observed for 5 minutes to confirm successful hemostasis. All patients will be followed for 28 days to assess the occurrence of post-procedural rebleeding.

Timeline

Start
2026-07-01
Primary completion
2027-12-31
Completion
2027-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sucralfate Unknown 3 g Other
Subject Tranexamic Acid Small molecule 1.5 g Other

Indications

No indication recorded.